Rephonic
Artwork for Multiple Myeloma Hub

Multiple Myeloma Hub

Scientific Education Support
Multiple Myeloma
CAR T-Cell Therapy
Relapsed/refractory Multiple Myeloma
Cilta-Cel
Elrenatumab
Clinical Trials
Quality Of Life
Patient-Reported Outcomes
Magestek-1 Trial
Teclistomab
Cartitude-2
Cartitude-4
Bispecific Antibodies
Cytokine Release Syndrome
Phase 2 Trials
ECOG Performance Score
European Medicines Agency
Belantamab Mafodotin
BCMA CAR T-Cells
Dexamethasone

The Multiple Myeloma Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in multiple myeloma. Our aim is to enhance knowledge in multiple myeloma, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management.

Hosted on Acast. See acast.com/privacy for more information.... more

PublishesWeeklyEpisodes75Founded5 years ago
Number of ListenersCategory
Education

Listen to this Podcast

Artwork for Multiple Myeloma Hub

Latest Episodes

The Multiple Myeloma Hub spoke with Rakesh Popat, University College Hospital, London, UK. We asked about clinical experience with belantamab mafodotin, with a focus on strategies for managing ocular toxicity.

During this interview, Popat discussed ... more

The Multiple Myeloma Hub spoke with Paul Richardson, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, Massachusetts, US. We asked about the clinical implications of findings from the phase III MIDAS trial (NCT04934475), wh... more

The Multiple Myeloma Hub spoke with Paul Richardson, Dana-Farber Cancer Institute, Boston, US. We asked, How might the clinical development of cereblon E3 ligase modulators (CELMoDs) impact the treatment paradigm for multiple myeloma (MM)?

During t... more

The Multiple Myeloma Hub spoke with María-Victoria Mateos, University Hospital of Salamanca, ES. We asked about the latest findings from the updated follow-up of CARTITUDE-2 Cohort D.

During this interview, Mateos discussed the latest outcomes from... more

The Multiple Myeloma Hub spoke with María-Victoria Mateos, University Hospital of Salamanca, Salamanca, Spain. We asked about the evolving diagnostic criteria for high-risk smoldering MM.

During this interview, Mateos discussed the latest updates i... more

The Multiple Myeloma Hub spoke with Ravi Vij, Washington University, St. Louis, US. We asked, What combination regimens including bispecific T-cell engagers (BiTEs) are being evaluated for the treatment of relapsed/refractory multiple myeloma (RRMM)?... more

The Multiple Myeloma Hub spoke to Irene Ghobrial, Dana-Farber Cancer Institute, Boston, US. We asked about risk stratification and prognosis in smoldering multiple myeloma (MM).

During this interview, Ghobrial discussed risk stratification and prog... more

The Multiple Myeloma Hub spoke with Alexander Lesokhin, Memorial Sloan Kettering Cancer Center, New York, US. We asked, What combination regimens containing B-cell maturation antigen (BCMA)-directed bispecific antibodies are being evaluated for multi... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Talking Points

Recent interactions between the hosts and their guests.

CAR T-cell therapies in clinical practice
Q: What is the next step in extremely high-risk patients?
Perhaps starting to combine immunotherapies with a CAR T-cell product for those patients.
Symposium | The next wave of immune-based therapies: What you need to know in relapsed/refractory multiple myeloma
Q: What are the key considerations when selecting between BCMA GPRC5D or FCRH5 targeted therapies?
Access to therapies and side effect management are crucial, with BCMA therapies currently having more data and easier access for patients.
Symposium | The next wave of immune-based therapies: What you need to know in relapsed/refractory multiple myeloma
Q: What biomarkers do you think are showing the most promise for tracking resistance to new wave immunotherapies?
The key biomarkers involve understanding the antigens expressed by patients and the level of mutations, which affect their response to therapies.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Multiple Myeloma Hub

What is Multiple Myeloma Hub about and what kind of topics does it cover?

Content focuses on advancements in the treatment and management of multiple myeloma, featuring insights from various medical experts. Key topics discussed include targeted therapies such as CAR T-cell therapies, immune-based approaches, and the impact of specific treatments on patients' quality of life. The emphasis on new clinical trial data and emerging therapeutic options highlights ongoing developments in the field, making it a valuable resource for health care professionals, researchers, and patients alike. Unique to this content is its commitment to providing evidence-based information directly from leading experts in hematology, presenting the latest findings in an accessible format.

Where can I find podcast stats for Multiple Myeloma Hub?

Rephonic provides a wide range of podcast stats for Multiple Myeloma Hub. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Multiple Myeloma Hub and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Multiple Myeloma Hub get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Multiple Myeloma Hub, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Multiple Myeloma Hub?

Rephonic provides comprehensive predictive audience data for Multiple Myeloma Hub, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Multiple Myeloma Hub have?

To see how many followers or subscribers Multiple Myeloma Hub has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Multiple Myeloma Hub?

These podcasts share a similar audience with Multiple Myeloma Hub:

1. Two Onc Docs
2. Medscape InDiscussion: Multiple Myeloma
3. Stuff You Missed in History Class
4. JAMA Medical News
5. The Myeloma Minutes

How many episodes of Multiple Myeloma Hub are there?

Multiple Myeloma Hub launched 5 years ago and published 75 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Multiple Myeloma Hub?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Multiple Myeloma Hub?

Rephonic pulls ratings and reviews for Multiple Myeloma Hub from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Multiple Myeloma Hub?

Rephonic provides full transcripts for episodes of Multiple Myeloma Hub. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days